Vontobel Holding Ltd. Decreases Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Vontobel Holding Ltd. lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 1.8% in the 4th quarter, Holdings Channel reports. The firm owned 4,416 shares of the financial services provider’s stock after selling 81 shares during the period. Vontobel Holding Ltd.’s holdings in iShares Biotechnology ETF were worth $600,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of IBB. Glass Jacobson Investment Advisors llc grew its holdings in shares of iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 122 shares during the period. Values First Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth $43,000. Horizon Bancorp Inc. IN bought a new stake in shares of iShares Biotechnology ETF in the third quarter worth $44,000. Tennessee Valley Asset Management Partners bought a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth $44,000. Finally, Column Capital Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the third quarter worth $49,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.1 %

Shares of IBB opened at $126.11 on Tuesday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16. The business has a fifty day moving average of $134.89 and a 200 day moving average of $129.71.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.40%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.